Meta-analyses of the effects of DPP-4 inhibitors, SGLT2 inhibitors and GLP1 receptor analogues on cardiovascular death, myocardial infarction, stroke and hospitalization for heart failure - Sinha, B; Ghosal, S (Diabetes Res Clin Pract, 2019)